| Schedule of receivables and payables account balances related parties |
| Schedule of receivables and payables account balances related parties |
|
|
|
|
|
|
| |
|
|
|
|
June 30,
2026 |
|
| Related party |
|
Name of entity |
|
|
Payables |
|
|
Receivables |
|
| |
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
|
$ |
- |
|
|
|
54,058 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
|
|
32,435 |
|
|
|
- |
|
| Total |
|
|
|
|
$ |
32,435 |
|
|
|
54,058 |
|
| |
|
|
|
|
December 31,
2025 |
|
| Related party |
|
Name of entity |
|
|
Payables |
|
|
Receivables |
|
| |
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
|
$ |
- |
|
|
|
52,918 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
|
|
31,751 |
|
|
|
- |
|
| Total |
|
|
|
|
$ |
31,751 |
|
|
|
52,918 |
|
|
| Schedule of receivables and payables account balances related parties |
|
|
|
|
|
|
| |
|
|
|
|
December 31,
2025 |
|
| Related party |
|
Name of entity |
|
|
Payables |
|
|
Receivables |
|
| |
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
|
$ |
- |
|
|
|
52,918 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
|
|
31,751 |
|
|
|
- |
|
| Total |
|
|
|
$ |
31,751 |
|
|
|
52,918 |
|
| |
|
|
|
|
December 31,
2024 |
|
| Related party |
|
Name of entity |
|
|
Payables |
|
|
Receivables |
|
| |
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
|
$ |
- |
|
|
|
50,618 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
|
|
30,371 |
|
|
|
- |
|
| Total |
|
|
|
$ |
30,371 |
|
|
|
50,618 |
|
|
| Schedule of significant financial transactions with related parties |
| Schedule of significant financial transactions with related parties |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
2026 |
|
| Related party |
|
Name of entity |
|
Account Name |
|
|
January 1 |
|
|
Increase |
|
|
Decrease |
|
|
June 30 |
|
| |
|
|
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
Other receivables |
|
|
$ |
52,918 |
|
|
|
1,140 |
(*1) |
|
|
- |
|
|
|
54,058 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
Promissory note payables |
|
|
|
31,751 |
|
|
|
684 |
(*2) |
|
|
- |
|
|
|
32,435 |
|
| |
|
|
|
|
|
|
2025 |
|
| Related party |
|
Name of entity |
|
Account Name |
|
|
January 1 |
|
|
Increase |
|
|
Decrease |
|
|
June 30 |
|
| |
|
|
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
Other receivables |
|
|
$ |
50,618 |
|
|
|
1,140 |
(*3) |
|
|
- |
|
|
|
51,758 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
Promissory note payables |
|
|
|
30,371 |
|
|
|
684 |
(*4) |
|
|
- |
|
|
|
31,055 |
|
|
(*1) |
The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June 30, 2026. |
|
(*2) |
The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June 30, 2026. |
|
(*3) |
The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the six months ended June 30, 2025. |
|
(*4) |
The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the six months ended June 30, 2025. |
|
| Schedule of significant financial transactions with related parties |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
2025 |
|
| Related party |
|
Name of entity |
|
Account Name |
|
|
January 1 |
|
|
Increase |
|
|
Decrease |
|
|
December 31 |
|
| |
|
|
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
Other receivables |
|
|
$ |
50,618 |
|
|
|
2,300 |
(*1) |
|
|
- |
|
|
|
52,918 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
Promissory note payables |
|
|
|
30,371 |
|
|
|
1,380 |
(*2) |
|
|
- |
|
|
|
31,751 |
|
| Total |
|
|
|
$ |
80,989 |
|
|
|
3,680 |
|
|
|
- |
|
|
|
84,669 |
|
| |
|
|
|
|
|
|
2024 |
|
| Related party |
|
Name of entity |
|
Account Name |
|
|
September 24
(Inception) |
|
|
Increase |
|
|
Decrease |
|
|
December 31 |
|
| |
|
|
|
|
|
|
(In U.S. Dollar) |
|
| Individual that has control over the Company |
|
EUN JONG CHOI |
|
Other receivables |
|
|
$ |
- |
|
|
|
50,618 |
(*3) |
|
|
- |
|
|
|
50,618 |
|
| Other related party |
|
CUBEBIO Co., Ltd. |
|
Promissory note payables |
|
|
|
- |
|
|
|
30,371 |
(*4) |
|
|
- |
|
|
|
30,371 |
|
| Total |
|
|
|
$ |
- |
|
|
|
80,989 |
|
|
|
- |
|
|
|
80,989 |
|
| (*1) |
The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the year ended December 31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026. |
| (*2) |
The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the year ended December 31, 2025, which originally commenced in 2024 and was subsequently extended from 2025 to 2026. |
| (*3) |
The Company recognized interest income accrued under an agreement to issue 50,000 shares of common share in consideration for gross proceeds of $50,000 during the period from September 24, 2024 (inception), through December 31, 2024. |
| (*4) |
The Company recognized interest expense accrued under a promissory note to pay $30,000 issued for common share issuing-related costs and organization costs paid by CubeBio Co., Ltd. on behalf of the Company during the period from September 24, 2024 (inception), through December 31, 2024. |
|